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Clinically important lead-induced tricuspid regurgitation
(LITR) is an uncommon complication following cardiac
device implantation. Surgical removal and replacement of a
lead may improve heart failure caused by LITR.1 Percuta-
neous lead extraction and reimplantation may also improve
or correct LITR.2 However, whether severe tricuspid regur-
gitation (TR) is caused by a lead is often unclear, especially
in patients with left ventricular (LV) dysfunction; worsening
heart failure in such patients is most often attributed to
progression of LV dysfunction.1–3
Echocardiography may clarify whether worsening heart
failure is due to LITR. It is only occasionally obvious that a
lead is the culprit.1,3 However, other ﬁndings may still
implicate the lead. Right heart failure disproportionate to
that expected for the degree of LV dysfunction should
suggest possible LITR. In left heart failure, LV end-
diastolic pressure (LVEDP) is expected to be greater than
right ventricular (RV) end-diastolic pressure (RVEDP): the
positive transseptal pressure gradient ( LVEDP  RVEDP)
would cause the ventricular septum to be concave toward the
LV.4,5 If the ventricular septum is ﬂattened, the transseptal
pressure gradient is close to zero or negative; that is, RVEDP
is greater than or equal to LVEDP. This should suggest other
possible causes of RV failure, including LITR.
Our experience suggests that the reasoning described
above can help determine whether the lead is responsible for,
or contributes to, severe TR and that percutaneous lead
reimplantation may be beneﬁcial.Methods
Percutaneous lead replacement for presumed LITR was
performed in 6 patients between July 2001 and July 2012.
Echocardiograms were reviewed to assess biventricular
function, lead relationship to the tricuspid valve (TV),KEYWORDS Lead-induced tricuspid regurgitation; Heart failure; Lead
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mated peak systolic pulmonary artery pressure.
Results
Table 1 lists the clinical characteristics of the 6 patients and
the devices used. Table 2 summarizes the outcomes. LITR
was veriﬁed in 4 patients (cases 1, 2, 4, and 6) by substantial
clinical improvement. Case 5 needed an open TV repair
because a leaﬂet was torn during lead extraction. In case 3,
the cause of heart failure remained unclear. VSF was present
in the 5 available echocardiograms.
Case 1
A 68-year-old male patient with moderate LV dysfunction
and prior coronary artery bypass surgery had a pacemaker
implanted in 2006, which was upgraded to a cardiac
resynchronization therapy with deﬁbrillator device in 2009.
He subsequently developed heart failure resistant to medical
therapy.
Echocardiography revealed severe TR, but the effect of
the lead was unclear. The estimated peak RV systolic
pressure was 33 mm Hg; there was mild RV dysfunction.
Initially, the implantable cardioverter-deﬁbrillator (ICD)
lead was removed percutaneously and a deﬁbrillator coil was
placed in the azygous vein. The abandoned pace/sense lead
was not removed. TR and heart failure remained severe, and
3 months later, the pace/sense lead was replaced percuta-
neously. TR was improved, his heart failure was easily
controlled without diuretics, and he returned to active living.
Follow-up echocardiography showed normal ventricular
septal shape.
Case 2
A 72-year-old male patient (LV ejection fraction 12%) with
prior coronary artery bypass surgery and a pacemaker
presented 6 months later with severe right heart failure.
There was severe TR with clear lead impingement, an
estimated peak RV systolic pressure of 51 mm Hg, mild-
to-moderate RV dysfunction, and VSF.
The lead was replaced percutaneously 11 months follow-
ing the original implantation. He lost 5.6 kg within 4 days.
He remains stable 6 years later without diuretics. Anpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.01.004
KEY TEACHING POINTS
 Lead-induced tricuspid regurgitation is
underrecognized, and increased vigilance is needed
by health care professionals managing patients
with cardiac rhythm management devices.
 Echocardiography may be a valuable tool for
establishing lead-induced tricuspid regurgitation.
 Contrary to traditional teaching, patients with
lead-induced tricuspid regurgitation, even with
leads that are a few years old, may still beneﬁt from
removal of the lead.
Heart Rhythm Case Reports, Vol 2, No 2, March 2016174echocardiogram recorded 2 years postrevision showed mod-
erate TR and normal ventricular septal shape.Case 3
A 79-year-old male patient with mitral regurgitation and a
pacemaker presented 6 years later with severe heart failure
and TR, most likely a ruptured TV chord, moderate-to-severe
mitral regurgitation, normal LV systolic function, an esti-
mated peak RV systolic pressure of 54 mm Hg, and mild RV
dysfunction. There was VSF.
He underwent percutaneous lead replacement; intraoper-
ative transesophageal echocardiography did not clarify
the cause of TR. Subsequently, TR and VSF appeared
unchanged, and the patient died several months later. The
cause of the persistent heart failure was not clariﬁed.Case 4
An 82-year-old male patient with a previous mitral valve
repair had an ICD implanted after a cardiac arrest. The device
was later upgraded to a dual-chamber ICD, and the RV lead
was replaced. He developed progressive heart and renal
failure requiring frequent hospitalizations. A furosemide
infusion (8 mg/h) caused a loss of 24 kg, but severe TR
persisted.
LV function was moderately reduced; there was mild-to-
moderate mitral regurgitation, an estimated peak RV systolic
pressure of 56 mm Hg, moderate RV dysfunction, and VSF.Table 1 Patient characteristics and devices used
Case no. Age (y) Sex Clinical diagnosis Device
1 68 M Ischemic CMP; CRT-D
CHB
2 72 M A. ﬁb; bradycardia VVI PPM
3 79 M A. ﬁb; bradycardia VVI PPM
4 82 M Mitral valve repair; VF DDD ICD
5 70 F SSS VVI
PPM
6 24 F CHB VDD
PPM
AF ¼ active ﬁxation; A. ﬁb ¼ atrial ﬁbrillation; CHB ¼ complete heart block
deﬁbrillator; F ¼ female; ICD ¼ implantable cardioverter-deﬁbrillator; M ¼ ma
syndrome; U ¼ unknown lead type; VF ¼ ventricular ﬁbrillation.After percutaneous lead replacement, TR was mild to
moderate with normalization of septal shape. A furosemide
infusion (2 mg/h) caused loss of another 5.9 kg following the
procedure. The serum creatinine level improved from 350 to
140 μmol/L. Subsequently, he required furosemide 20 mg
twice daily.
Case 5
A 70-year-old female patient had a pacemaker implanted and
a new RV lead was placed 4 years later for lead failure; the
old lead was abandoned. She developed severe right heart
failure 10 years later.
Echocardiography showed moderate-to-severe aortic and
mitral regurgitation with normal LV size and systolic
function. There was severe TR, with the lead impinging on
the posterior tricuspid leaﬂet, an estimated peak RV systolic
pressure of 70 mm Hg, and normal RV systolic function.
Images were not available for review, and septal shape was
not described in the report.
After percutaneous lead replacement, TR was mild to
moderate and there was spontaneous diuresis in hospital with
no alteration in diuretic dose. The follow-up echocardiogram
was not available to assess septal shape. She remained
asymptomatic 5 years later.
Case 6
A 24-year-old female patient had a pacemaker implanted at
the age of 5 years. Eleven years later, the lead failed and she
had a passive ﬁxation VDD pacemaker implanted. Severe
TR was diagnosed 7 years later. There was no history of
congenital or acquired TV disease; there was minimal TR
before lead insertion.
LV size and function were normal; there was severe TR,
RV dilation (RV basal diameter 6.1 cm) with normal RV
function, and estimated pulmonary artery pressure. There
was VSF. A lead impinged on the septal leaﬂet. The chest
radiograph suggested that the 2 leads were at opposite sides
of the tricuspid annulus, possibly “spreading” the leaﬂets
apart (Figure 1).
She underwent lead reimplantation of a new DDDR
system. However, a leaﬂet of the valve became ﬂail. She
remained well, not requiring any diuretics, but developedNo. of leads Lead type Years from insertion to removal
2 5076 AF 6.2
7122 AF 4.3
1 5076 AF 0.9
1 4088 AF 6.8
1 0181 AF 4.2
2 4082 PF 10.2
430-10 PF 6.4
2 5038 PF 8.4
U 19
; CMP ¼ cardiomyopathy; CRT-D ¼ cardiac resynchronization therapy with
le; PF ¼ passive ﬁxation; PPM ¼ permanent pacemaker; SSS ¼ sick sinus
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175Wardell et al Diagnosis of LITRerythrocytosis owing to right-to-left shunting across a patent
foramen ovale. VSF persisted. She then underwent surgical
repair of her TV and patent foramen ovale closure.Discussion
In this report of 6 patients with a presumed diagnosis of
LITR, we made several important observations. We present a
novel approach to the diagnosis of LITR, which, although
not necessarily diagnostic in each instance, may provide the
clinician with sufﬁcient conﬁdence to reimplant the lead. We
also show that percutaneous lead reimplantation may be
more beneﬁcial than has been suggested recently.2 Perhaps
most importantly, 5 of 6 patients came from a relatively
small academic practice where more than 50 cardiologists
work. This suggests that LITR is often unrecognized.Diagnosis of LITR
Echocardiographic evidence of increased TR following
device implantation occurs in 7.2%–39% of cases.5,6 Echo-
cardiography has been disappointing in attributing heart
failure to LITR. Impingement of the lead on the TV may be
obvious, but the effect of the lead on valve function is
frequently unclear.1,3,7 Nevertheless, worsening heart failure
in a patient with an RV lead and severe TR should still raise
suspicion of LITR. If there is no associated structural heart
disease, the lead is likely the culprit. Since patients with
implantable leads increasingly have other potential causes of
heart failure, one should consider the possibility of LITR.
When right heart failure with TR is worse than expected
from any associated left-sided heart disease, one should
suspect LITR. That diagnosis would be supported by the
presence of VSF, which implies that RVEDP is greater than
expected if it is secondary to left failure (Figure 2). If there is
no other independent cause of RV failure, that is, conditions
other than left heart failure causing pulmonary hypertension
or RV dysfunction, LITR is likely. If VSF is absent, the
effect of the lead on TR is more difﬁcult to determine unless
it clearly prevents leaﬂet coaptation.
The time from ﬁrst implantation to lead removal for
severe TR varied from 11 months to 18 years in our patients.
It is not known how long it took to develop severe TR and
how RV remodeling may have contributed to TR over time.
There was similar variation in delay from implantation to
surgery in a Mayo Clinic series of 41 patients.1 It seems
likely that the development of LITR is frequently time-
dependent; studies suggest that there is no or only minimal
worsening of TR shortly after implantation.8,9Mechanisms of LITR
Four mechanisms of LITR were well documented in con-
ﬁrmed LITR.1 The lead may impinge on the valve, perforate
a leaﬂet, be entangled in the TV apparatus, or adhere to
the valve.1,10,11 With time, thrombosis and encapsulation
can also occur.12,13 RV remodeling secondary to TR may
contribute to increasing TR.
Figure 1 Chest radiograph of case 6, with lead position from 2 intracardiac leads suggestive of interaction with valve leaﬂets (she also had an abandoned lead
from an abdominal system seen on the images).
Heart Rhythm Case Reports, Vol 2, No 2, March 2016176One of our patients developed a ﬂail tricuspid leaﬂet
during lead extraction, which was apparent on the intra-
operative transesophageal echocardiography. The laser
sheath had reached past the tricuspid annulus; how the
leaﬂet became damaged is unclear. This has been reported in
9% of percutaneous procedures.14 Unfortunately, leaﬂet per-
foration has not been readily identiﬁable by 2-dimensional
echocardiography1,3,7 and the ability to clearly identify other
mechanisms is limited.Lead extraction/reimplantation
It appears that percutaneous lead extraction can be performed
with an acceptable risk of complications (given that the
occasional need to manage the procedure-related damage of
the TV is the same as the alternative open heart surgery).
Despite one of our patients not beneﬁting from the procedure
because of the damage of the valve, 4 of 6 patients stillFigure 2 Ventricular septal ﬂattening at end diastole. The left image is for case
shows an example of normal septal shape at end diastole.derived substantial clinical beneﬁt without an open heart
surgery.
The authors of a recent report2 of a small series of patients
suggested that there is limited beneﬁt of percutaneous lead
replacement for LITR. We suggest that identifying the lead
as the culprit is a critical ﬁrst step, which too often has been
problematic; our approach correctly diagnosed LITR in 4 of
our 6 patients who improved and almost certainly in the one
who went on to an open heart surgery.
Incidence of LITR
The fact that 5 of our patients were referred by 1 of more than
50 cardiologists suggests that LITR is often unrecognized.
Others have reported a 2.8%–7% incidence of LITR at
surgery, but the indication for the surgery was only rarely
related primarily to TR, which also suggests that LITR may
erroneously be attributed to other structural abnormal-
ities.1,10 Prospective studies will be required to determine1, showing ventricular septal ﬂattening at end diastole, and the right image
177Wardell et al Diagnosis of LITRthe natural history of asymptomatic TR detected by echo-
cardiography and the true incidence and evolution of
LITR.15
Study limitations
The present study is limited by its small sample size and the
fact that it is retrospective and that a systematic approach was
not applied to all patients. However, follow-up was complete
and those who responded well to lead replacement had clear
clinical improvement.
Conclusion
Our limited experience with patients with presumed LITR
and severe heart failure suggests that it is possible to
diagnose this problem using a novel clinical echocardio-
graphic approach to predict beneﬁts of percutaneous lead
reimplantation. This approach needs to be assessed in a
larger number of patients to clarify its predictive power.
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